GeoVax Labs Shares Are Trading Higher. Earlier in the Week, the Company Received a BARDA Project NextGen Award to Conduct a Phase 2b Clinical Study Evaluating Its COVID-19 Vaccine Candidate, GEO-CM04S1.
GeoVax Labs Shares Are Trading Higher. Earlier in the Week, the Company Received a BARDA Project NextGen Award to Conduct a Phase 2b Clinical Study Evaluating Its COVID-19 Vaccine Candidate, GEO-CM04S1.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.